The link between chronic periodontitis and COPD: A common role for the neutrophil?

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Usher, Adam K H ^a   Stockley, Robert A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Emphysema; Neutrophil; Neutrophil extracellular trap; Oxidative stress; Periodontal diseases; Protease proteinase

Indexed keywords

ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; CATHEPSIN B; CATHEPSIN G; CD8 ANTIGEN; CHEMOATTRACTANT; CIGARETTE SMOKE; CYSTATIN C; CYSTEINE PROTEINASE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; NITRIC OXIDE; PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE DEIMINASE TYPE IV; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR 3; SUPEROXIDE DISMUTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALVEOLAR BONE LOSS; ARTICLE; BODY MASS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PERIODONTITIS; DENDRITIC CELL; DENTAL FLOSS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FENTON REACTION; FORCED EXPIRATORY VOLUME; HOST SUSCEPTIBILITY; HUMAN; HYPOTHESIS; INFLAMMATORY CELL; INNATE IMMUNITY; LUNG EMPHYSEMA; LUNG PARENCHYMA; MACROPHAGE; MUSCLE DISEASE; NEUTROPHIL; NEUTROPHIL GRANULE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARTICULATE MATTER; PATHOGENESIS; PATHOPHYSIOLOGY; SMOKING; TOOTH BRUSHING; UPREGULATION;

ANIMALS; CHRONIC PERIODONTITIS; HUMANS; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84887931908     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-241     Document Type: Article

References (116)

1. Morris AJ, Steele J, White DA. The oral cleanliness and periodontal health of UK adults in 1998. Br Dent J 2001, 191:186-192.
2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global burden of disease study 2010. Lancet 2012, 380:2163-2196. 10.1016/S0140-6736(12)61729-2, 23245607.
3. Kinane DF, Preshaw PM, Loos BG. Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions-consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 2011, 38:44-48.
4. Listgarten MA. Pathogenesis of periodontitis. J Clin Periodontol 1986, 13:418-430. 10.1111/j.1600-051X.1986.tb01485.x, 3522650.
5. Laine ML, Crielaard W, Loos BG. Genetic susceptibility to periodontitis. Periodontol 2000 2012, 58:37-68. 10.1111/j.1600-0757.2011.00415.x, 22133366.
6. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757. 10.1016/S0140-6736(06)68770-9, 16731270.
7. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011, 378:1015-1026. 10.1016/S0140-6736(11)60988-4, 21907865.
8. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002, 121:151S-155S. 10.1378/chest.121.5_suppl.151S, 12010844.
9. Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:S17-S20. 10.1164/ajrccm.160.supplement_1.6, 10556163.
10. Travis J, Pike R, Imamura T, Potempa J. The role of proteolytic enzymes in the development of pulmonary emphysema and periodontal disease. Am J Respir Crit Care Med 1994, 150:S143-S146. 10.1164/ajrccm/150.6_Pt_2.S143, 7952650.
11. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome?. Lancet 2007, 370:797-799. 10.1016/S0140-6736(07)61383-X, 17765529.
12. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165-1185. 10.1183/09031936.00128008, 19407051.
13. Franciosi LG, Page CP, Celli BR, Cazzola M, Walker MJ, Danhof M, Rabe KF, Della Pasqua OE. Markers of exacerbation severity in chronic obstructive pulmonary disease. Respir Res 2006, 7:74. 10.1186/1465-9921-7-74, 1481583, 16686949.
14. Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest 2011, 139:165-173. 10.1378/chest.10-1252, 21208876.
15. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010, 65:956-962. 10.1136/thx.2009.128082, 20871122.
16. Van der Molen T. Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J 2010, 19:326-334. 10.4104/pcrj.2010.00053, 20842323.
17. Kuo LC, Polson AM, Kang T. Associations between periodontal diseases and systemic diseases: a review of the inter-relationships and interactions with diabetes, respiratory diseases, cardiovascular diseases and osteoporosis. Public Health 2008, 122:417-433. 10.1016/j.puhe.2007.07.004, 18028967.
18. Cullinan MP, Ford PJ, Seymour GJ. Periodontal disease and systemic health: current status. Aust Dent J 2009, 54:S62-S69.
19. Lee HJ, Garcia RI, Janket SJ, Jones JA, Mascarenhas AK, Scott TE, Nunn ME. The association between cumulative periodontal disease and stroke history in older adults. J Periodontol 2006, 77:1744-1754. 10.1902/jop.2006.050339, 17032119.
20. Wactawski-Wende J. Periodontal diseases and osteoporosis: association and mechanisms. Ann Periodontol 2001, 6:197-208. 10.1902/annals.2001.6.1.197, 11887465.
21. Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, Taylor R. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012, 55:21-31. 10.1007/s00125-011-2342-y, 3228943, 22057194.
22. Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol 2010, 6:727-730. 10.1038/nrrheum.2010.139, 20820197.
23. Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, Davey Smith G, Upton M, Hawthorne V, Sin DD, Man SF, Van Eeden S, Mapel DW, Vestbo J. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006, 27:627-643. 10.1183/09031936.06.00024605, 16507865.
24. Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax 2006, 61:472-477. 10.1136/thx.2005.052449, 2111202, 16517577.
25. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, BOLD Collaborative Research Group International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370:741-750. 10.1016/S0140-6736(07)61377-4, 17765523, BOLD Collaborative Research Group.
26. Matkovic Z, Miravitlles M. Chronic bronchial infection in COPD. Is there an infective phenotype?. Respir Med 2013, 107:10-22. 10.1016/j.rmed.2012.10.024, 23218452.
27. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370:765-773. 10.1016/S0140-6736(07)61380-4, 17765526.
28. Bolin A, Eklund G, Frithiof L, Lavstedt S. The effect of changed smoking habits on marginal alveolar bone loss. A longitudinal study. Swed Dent J 1993, 17:211-216.
29. Burt BA, Ismail AI, Morrison EC, Beltran ED. Risk factors for tooth loss over a 28-year period. J Dent Res 1990, 69:1126-1130. 10.1177/00220345900690050201, 2335645.
30. Grossi SG, Zambon JJ, Ho AW, Koch G, Dunford RG, Machtei EE, Norderyd OM, Genco RJ. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994, 65:260-267. 10.1902/jop.1994.65.3.260, 8164120.
31. Pihlstrom BL. Periodontal risk assessment, diagnosis and treatment planning. Periodontol 2000 2001, 25:37-58. 10.1034/j.1600-0757.2001.22250104.x, 11155181.
32. Cianciola LJ, Park BH, Bruck E, Mosovic L, Genco RJ. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc 1982, 104:653-660.
33. Gershon AS, Dolmage TE, Stephenson A, Jackson B. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD 2012, 9:216-226. 10.3109/15412555.2011.648030, 22497534.
34. Borrell LN, Beck JD, Heiss G. Socioeconomic disadvantage and periodontal disease: the Dental Atherosclerosis Risk in Communities study. Am J Public Health 2006, 96:332-339. 10.2105/AJPH.2004.055277, 1470476, 16380570.
35. Scannapieco FA, Papandonatos GD, Dunford RG. Associations between oral conditions and respiratory disease in a national sample survey population. Ann Periodontol 1998, 3:251-256. 10.1902/annals.1998.3.1.251, 9722708.
36. Scannapieco FA, Ho AW. Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. J Periodontol 2001, 72:50-56. 10.1902/jop.2001.72.1.50, 11210073.
37. Hayes C, Sparrow D, Cohen M, Vokonas PS, Garcia RI. The association between alveolar bone loss and pulmonary function: the VA Dental Longitudinal Study. Ann Periodontol 1998, 3:257-261. 10.1902/annals.1998.3.1.257, 9722709.
38. National Clinical Guideline Centre. Chronic Obstructive Pulmonary Disease Management of chronic obstructive pulmonary disease in adults in primary and secondary care 2010, London: National Clinical Guideline Centre, [http://guidance.nice.org.uk/CG101], National Clinical Guideline Centre. Chronic Obstructive Pulmonary Disease.
39. Deo V, Bhongade ML, Ansari S, Chavan RS. Periodontitis as a potential risk factor for chronic obstructive pulmonary disease: a retrospective study. Indian J Dent Res 2009, 20:466-470. 10.4103/0970-9290.59456, 20139573.
40. Leuckfeld I, Obregon-Whittle MV, Lund MB, Geiran O, Bjortuft O, Olsen I. Severe chronic obstructive pulmonary disease: association with marginal bone loss in periodontitis. Respir Med 2008, 102:488-494. 10.1016/j.rmed.2007.12.001, 18191392.
41. Prasanna SJ. Causal relationship between periodontitis and chronic obstructive pulmonary disease. J Indian Soc Periodontol 2011, 15:359-365. 10.4103/0972-124X.92570, 3283933, 22368360.
42. Si Y, Fan H, Song Y, Zhou X, Zhang J, Wang Z. Association between periodontitis and chronic obstructive pulmonary disease (COPD) in a Chinese population. J Periodontol 2012, 83:1288-1296. 10.1902/jop.2012.110472, 22248220.
43. Peter KP, Mute BR, Doiphode SS, Bardapurkar SJ, Borkar MS, Raje DV. Association between periodontal disease and chronic obstructive pulmonary disease - A reality or just a dogma. J Periodontol 2013, [Epub ahead of print].
44. Zhou X, Wang Z, Song Y, Zhang J, Wang C. Periodontal health and quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2011, 105:67-73. 10.1016/j.rmed.2010.06.017, 20630736.
45. Wang Z, Zhou X, Zhang J, Zhang L, Song Y, Hu FB, Wang C. Periodontal health, oral health behaviours, and chronic obstructive pulmonary disease. J Clin Periodontol 2009, 36:750-755. 10.1111/j.1600-051X.2009.01448.x, 19614723.
46. Liu Z, Zhang W, Zhang J, Zhou X, Zhang L, Song Y, Wang Z. Oral hygiene, periodontal health and chronic obstructive pulmonary disease exacerbations. J Clin Periodontol 2012, 39:45-52. 10.1111/j.1600-051X.2011.01808.x, 22092913.
47. Yildirim E, Kormi I, Basoglu OK, Gurgun A, Kaval B, Sorsa T, Buduneli N. Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease. J Periodontal Res 2012, 48:269-275.
48. Carneiro LG, Venuleo C, Oppenheim FG, Salih E. Proteome data set of human gingival crevicular fluid from healthy periodontium sites by multidimensional protein separation and mass spectrometry. J Periodontal Res 2012, 47:248-262. 10.1111/j.1600-0765.2011.01429.x, 3272151, 22029670.
49. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, O'Connor CM. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997, 156:240-247. 10.1164/ajrccm.156.1.9612018, 9230755.
50. Azarpazhooh A, Leake JL. Systematic review of the association between respiratory diseases and oral health. J Periodontol 2006, 77:1465-1482. 10.1902/jop.2006.060010, 16945022.
51. Garcia RI, Nunn ME, Vokonas PS. Epidemiologic associations between periodontal disease and chronic obstructive pulmonary disease. Ann Periodontol 2001, 6:71-77. 10.1902/annals.2001.6.1.71, 11887473.
52. Hyman JJ, Reid BC. Cigarette smoking, periodontal disease: and chronic obstructive pulmonary disease. J Periodontol 2004, 75:9-15. 10.1902/jop.2004.75.1.9, 15025211.
53. Zeng XT, Tu ML, Liu DY, Zheng D, Zhang J, Leng W. Periodontal disease and risk of chronic obstructive pulmonary disease: a meta-analysis of observational studies. PLoS One 2012, 7:e46508. 10.1371/journal.pone.0046508, 3477163, 23094025.
54. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:S29-S32. 10.1164/ajrccm.160.supplement_1.9, 10556166.
55. Byers DE, Holtzman MJ. Alternatively activated macrophages and airway disease. Chest 2011, 140:768-774. 10.1378/chest.10-2132, 3168852, 21896520.
56. Cutler CW, Teng YT. Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists. Periodontol 2000 2007, 45:35-50. 10.1111/j.1600-0757.2007.00222.x, 2828688, 17850447.
57. Givi ME, Redegeld FA, Folkerts G, Mortaz E. Dendritic cells in pathogenesis of COPD. Curr Pharm Des 2012, 18:2329-2335. 10.2174/138161212800166068, 22390696.
58. Kheradmand F, Shan M, Xu C, Corry DB. Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence. Expert Rev Clin Immunol 2012, 8:285-292. 10.1586/eci.12.7, 3321360, 22390492.
59. Ali J, Pramod K, Tahir MA, Ansari SH. Autoimmune responses in periodontal diseases. Autoimmun Rev 2011, 10:426-431. 10.1016/j.autrev.2010.04.005, 21256252.
60. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010, 34:J258-J265. 10.1016/j.jaut.2009.12.003, 20042314.
61. Scott DA, Krauss J. Neutrophils in periodontal inflammation. Front Oral Biol 2012, 15:56-83. 3335266, 22142957.
62. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol 2012, 30:459-489. 10.1146/annurev-immunol-020711-074942, 22224774.
63. Burnett D, Chamba A, Hill SL, Stockley RA. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 1987, 2:1043-1046.
64. Woolhouse IS, Bayley DL, Lalor P, Adams DH, Stockley RA. Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease. Eur Respir J 2005, 25:612-617. 10.1183/09031936.05.00086304, 15802333.
65. Sapey E, Stockley JA, Greenwood H, Ahmad A, Bayley D, Lord JM, Insall RH, Stockley RA. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011, 183:1176-1186. 10.1164/rccm.201008-1285OC, 21257786.
66. Di SA, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998, 158:1277-1285. 10.1164/ajrccm.158.4.9802078, 9769292.
67. Confalonieri M, Mainardi E, Della PR, Bernorio S, Gandola L, Beghe B, Spanevello A. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 1998, 53:583-585. 10.1136/thx.53.7.583, 1745263, 9797758.
68. Subramanian DR, Jenkins L, Edgar R, Quraishi N, Stockley RA, Parr DG. Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography. Am J Respir Crit Care Med 2012, 186:1125-1132. 10.1164/rccm.201201-0051OC, 22837375.
69. Damiano VV, Tsang A, Kucich U, Abrams WR, Rosenbloom J, Kimbel P, Fallahnejad M, Weinbaum G. Immunolocalization of elastase in human emphysematous lungs. J Clin Invest 1986, 78:482-493. 10.1172/JCI112600, 423585, 3525610.
70. Nussbaum G, Shapira L. How has neutrophil research improved our understanding of periodontal pathogenesis?. J Clin Periodontol 2011, 38:49-59.
71. Ryder MI. Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol 2000 2010, 53:124-137. 10.1111/j.1600-0757.2009.00327.x, 20403109.
72. Donnelly LE, Barnes PJ. Defective phagocytosis in airways disease. Chest 2012, 141:1055-1062. 10.1378/chest.11-2348, 22474147.
73. Eriksson S. Pulmonary emphysema and alpha-1 antitrypsin deficiency. Acta Med Scand 1964, 175:197-205.
74. Janoff A, Sloan B, Weinbaum G, Damiano V, Sandhaus RA, Elias J, Kimbel P. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis 1977, 115:461-478.
75. Fujita J, Nelson NL, Daughton DM, Dobry CA, Spurzem JR, Irino S, Rennard SI. Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema. Am Rev Respir Dis 1990, 142:57-62. 10.1164/ajrccm/142.1.57, 2368980.
76. Owen CA. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008, 3:253-268. 2629972, 18686734.
77. D'Armiento J, Dalal SS, Okada Y, Berg RA, Chada K. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992, 71:955-961. 10.1016/0092-8674(92)90391-O, 1458541.
78. Lagente V, Manoury B, Nenan S, Le QC, Martin-Chouly C, Boichot E. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res 2005, 38:1521-1530. 10.1590/S0100-879X2005001000009, 16172745.
79. Wood AM, Stockley RA. The genetics of chronic obstructive pulmonary disease. Respir Res 2006, 7:130. 10.1186/1465-9921-7-130, 1626465, 17054776.
80. Ohlsson K, Olsson I, Tynelius-Bratthall G. Neutrophil leukocyte collagenase, elastase and serum protease inhibitors in human gingival crevicles. Acta Odontol Scand 1974, 32:51-59. 10.3109/00016357409002532, 4363636.
81. Peterson RJ, Marsh CL. The relationship of alpha1-antitrypsin to inflammatory periodontal disease. J Periodontol 1979, 50:31-35. 10.1902/jop.1979.50.1.31, 310876.
82. Ingman T, Sorsa T, Kangaspunta P, Konttinen YT. Elastase and alpha-1-proteinase inhibitor in gingival crevicular fluid and gingival tissue in adult and juvenile periodontitis. J Periodontol 1994, 65:702-709. 10.1902/jop.1994.65.7.702, 7608848.
83. Fokkema SJ, Timmerman MF, van der Weijden FA, Wolffe GN, Renggli HH. A possible association of alpha1-antitrypsin deficiency with the periodontal condition in adults. J Clin Periodontol 1998, 25:617-623. 10.1111/j.1600-051X.1998.tb02497.x, 9722265.
84. Wallin-Bengtsson V, Piitulainen E, Hamberg K, Lindh C, Bratthall G. Alpha-1-antitrypsin deficiency and periodontitis, a pilot study. Swed Dent J 2011, 35:33-40.
85. Figueredo CM, Gustafsson A. Activity and inhibition of elastase in GCF. J Clin Periodontol 1998, 25:531-535. 10.1111/j.1600-051X.1998.tb02483.x, 9696251.
86. Petropoulou P, Zhang Z, Curtis MA, Johnson NW, Hughes FJ, Winyard PG. Measurement of both native and inactivated forms of alpha1 proteinase inhibitor in human inflammatory extracellular fluids. J Clin Periodontol 2003, 30:795-801. 10.1034/j.1600-051X.2003.00369.x, 12956655.
87. Cox SW, Rodriguez-Gonzalez EM, Booth V, Eley BM. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis. J Periodontal Res 2006, 41:477-485. 10.1111/j.1600-0765.2006.00891.x, 16953825.
88. Loukides S, Bakakos P, Kostikas K. Oxidative stress in patients with COPD. Curr Drug Targets 2011, 12:469-477. 10.2174/138945011794751573, 21194408.
89. Neofytou E, Tzortzaki EG, Chatziantoniou A, Siafakas NM. DNA damage due to oxidative stress in chronic obstructive pulmonary disease (COPD). Int J Mol Sci 2012, 13:16853-16864. 10.3390/ijms131216853, 3546726, 23222732.
90. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989, 320:365-376. 10.1056/NEJM198902093200606, 2536474.
91. Folkerts G, Kloek J, Muijsers RB, Nijkamp FP. Reactive nitrogen and oxygen species in airway inflammation. Eur J Pharmacol 2001, 429:251-262. 10.1016/S0014-2999(01)01324-3, 11698045.
92. Mak JC. Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. Int J Tuberc Lung Dis 2008, 12:368-374.
93. Krinsky NI. Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 1992, 200:248-254. 10.3181/00379727-200-43429, 1579590.
94. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994, 91:10771-10778. 10.1073/pnas.91.23.10771, 45108, 7971961.
95. Chapple IL, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000 2007, 43:160-232. 10.1111/j.1600-0757.2006.00178.x, 17214840.
96. Deitch EA, Bridges W, Berg R, Specian RD, Granger DN. Hemorrhagic shock-induced bacterial translocation: the role of neutrophils and hydroxyl radicals. J Trauma 1990, 30:942-951. 10.1097/00005373-199008000-00002, 2167388.
97. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review). Int J Mol Med 1999, 4:223-230.
98. Mohsenin V, Gee JL. Oxidation of alpha 1-protease inhibitor: role of lipid peroxidation products. J Appl Physiol 1989, 66:2211-2215. 10.1063/1.344321, 2787317.
99. Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL, Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 154:813-816. 10.1164/ajrccm.154.3.8810624, 8810624.
100. Tzortzaki EG, Dimakou K, Neofytou E, Tsikritsaki K, Samara K, Avgousti M, Amargianitakis, Gousiou A, Menikou S, Siafakas NM. Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases. Chest 2012, 141:1243-1250. 10.1378/chest.11-1653, 22116800.
101. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000, 162:1175-1177. 10.1164/ajrccm.162.3.2001063, 10988150.
102. Dahl M, Bowler RP, Juul K, Crapo JD, Levy S, Nordestgaard BG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am J Respir Crit Care Med 2008, 178:906-912. 10.1164/rccm.200804-549OC, 2577726, 18703790.
103. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003, 124:1373-1380. 10.1378/chest.124.4.1373, 14555568.
104. Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, MacNee W, Agusti AG. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001, 56:432-437. 10.1136/thorax.56.6.432, 1746080, 11359957.
105. Gronert K, Kantarci A, Levy BD, Clish CB, Odparlik S, Hasturk H, Badwey JA, Colgan SP, Van Dyke TE, Serhan CN. A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J Immunol 2004, 172:1856-1861.
106. Matthews JB, Wright HJ, Roberts A, Cooper PR, Chapple IL. Hyperactivity and reactivity of peripheral blood neutrophils in chronic periodontitis. Clin Exp Immunol 2007, 147:255-264. 1810478, 17223966.
107. Grant MM, Brock GR, Matthews JB, Chapple IL. Crevicular fluid glutathione levels in periodontitis and the effect of non-surgical therapy. J Clin Periodontol 2010, 37:17-23. 10.1111/j.1600-051X.2009.01504.x, 19968740.
108. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535. 10.1126/science.1092385, 15001782.
109. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, Zychlinsky A. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007, 176:231-241. 10.1083/jcb.200606027, 2063942, 17210947.
110. Akong-Moore K, Chow OA, von Kockritz-Blickwede M, Nizet V. Influences of chloride and hypochlorite on neutrophil extracellular trap formation. PLoS One 2012, 7:e42984. 10.1371/journal.pone.0042984, 3418225, 22912772.
111. Metzler KD, Fuchs TA, Nauseef WM, Reumaux D, Roesler J, Schulze I, Wahn V, Papayannopoulos V, Zychlinsky A. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 2011, 117:953-959. 10.1182/blood-2010-06-290171, 3035083, 20974672.
112. Palmer LJ, Cooper PR, Ling MR, Wright HJ, Huissoon A, Chapple IL. Hypochlorous acid regulates neutrophil extracellular trap release in humans. Clin Exp Immunol 2012, 167:261-268. 10.1111/j.1365-2249.2011.04518.x, 3278692, 22236002.
113. Palmer LJ, Chapple IL, Wright HJ, Roberts A, Cooper PR. Extracellular deoxyribonuclease production by periodontal bacteria. J Periodontal Res 2012, 47:439-445. 10.1111/j.1600-0765.2011.01451.x, 22150619.
114. Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, Lohmeyer J, Preissner KT. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012, 7:e32366. 10.1371/journal.pone.0032366, 3289648, 22389696.
115. Thomas GM, Carbo C, Curtis BR, Martinod K, Mazo IB, Schatzberg D, Cifuni SM, Fuchs TA, von Andrian UH, Hartwig JH, Aster RH, Wagner DD. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 2012, 119:6335-6343. 10.1182/blood-2012-01-405183, 3383196, 22596262.
116. Kucukcoskun M, Baser U, Oztekin G, Kiyan E, Yalcin F. Initial periodontal treatment for prevention of chronic obstructive pulmonary disease exacerbations. J Periodontol 2012, 84:863-870.